**Question:** The enzyme involved in the metabolism of clopidogrel and proton pump inhibitors is:

A. CYP2C19
B. CYP3A4
C. CYP2C8
D. CYP2D6

**Core Concept:**

Clopidogrel is an antiplatelet drug used for preventing thrombosis and stroke. Proton pump inhibitors (PPIs) are a class of drugs that inhibit the secretion of gastric acid. Both clopidogrel and PPIs are primarily cleared from the body through the action of enzymes involved in drug biotransformation. The primary enzyme responsible for this clearance is Cytochrome P450 (CYP) enzyme family, specifically CYP enzymes.

**Why the Correct Answer is Right:**

Clopidogrel is primarily cleared via CYP2C19 and CYP3A4 enzymes. Among the given options, CYP2C19 is the correct answer because it is primarily responsible for the conversion of clopidogrel to its active form, which is essential for its pharmacological action. CYP2C19 is involved in the bioactivation of clopidogrel to its active form, which is responsible for its antiplatelet effect.

**Why Each Wrong Option is Incorrect:**

- CYP2C8: While CYP2C8 is involved in the clearance of some drugs, it is not primarily responsible for clopidogrel bioactivation.
- CYP3A4: Although CYP3A4 plays a role in the clearance of clopidogrel, its contribution is less significant compared to CYP2C19.
- CYP2D6: CYP2D6 is primarily involved in the clearance of drugs like codeine and debrisoquine, not clopidogrel.

**Clinical Pearl:**

Understanding the role of CYP enzymes in drug biotransformation is crucial for understanding drug-drug interactions, particularly when prescribing clopidogrel in combination with other medications like PPIs, which are primarily cleared by CYP3A4. This knowledge is essential in clinical practice to prevent potential drug interactions and ensure optimal treatment outcomes for patients.